Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:37
|
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 50 条
  • [41] Identification of a DNA Methylome Profile of Esophageal Squamous Cell Carcinoma and Potential Plasma Epigenetic Biomarkers for Early Diagnosis
    Li, Xufeng
    Zhou, Fuyou
    Jiang, Chunyu
    Wang, Yinuo
    Lu, Yanqiang
    Yang, Fei
    Wang, Nengchao
    Yang, Haijun
    Zheng, Yanfang
    Zhang, Jiren
    PLOS ONE, 2014, 9 (07):
  • [42] Evaluation of the circulating level of fibroblast activation protein a for diagnosis of esophageal squamous cell carcinoma
    Liao, Yuehua
    Xing, Shan
    Xu, Banglao
    Liu, Wanli
    Zhang, Ge
    ONCOTARGET, 2017, 8 (18) : 30050 - 30062
  • [43] Immunohistochemical examination of 5 novel biomarkers in oral epithelial dysplasia and squamous cell carcinoma
    AbdulMajeed, A.
    Chan, A.
    Stein, S.
    Farah, C. S.
    ORAL ONCOLOGY, 2011, 47 : S109 - S110
  • [44] Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis
    Wang, Xiao
    Lai, Minshan
    Wang, Yue
    Chai, Ruihuan
    Li, Nan
    Ou, Ling
    Zheng, Kai
    Li, Jieling
    Xu, Guifeng
    Wang, Shaoqi
    Dong, Yun
    Wang, Shaoxiang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [45] Six Novel Biomarkers for Diagnosis and Prognosis of Esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR
    Zheng, Liuhai
    Li, Linzhi
    Xie, Jun
    Jin, Hai
    Zhu, Naishuo
    JOURNAL OF CANCER, 2021, 12 (03): : 899 - 911
  • [46] Identification of genomic biomarkers associated with the clinicopathological parameters and prognosis of esophageal squamous cell carcinoma
    Shi, Zhi-Zhou
    Shang, Li
    Jiang, Yan-Yi
    Shi, Feng
    Xu, Xin
    Wang, Ming-Rong
    Hao, Jia-Jie
    CANCER BIOMARKERS, 2015, 15 (06) : 755 - 761
  • [47] Identification of potential biomarkers of esophageal squamous cell carcinoma using community detection algorithms
    Baruah, Bikash
    Karlo, Domum
    Dutta, Manash P.
    Banerjee, Subhasish
    Bhattacharyya, Dhruba K.
    INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS, 2025, 29 (1-2)
  • [48] Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers
    Lima, Sheila C. S.
    Hernandez-Vargas, Hector
    Simao, Tatiana
    Durand, Geoffroy
    Pinto Kruel, Cleber Dario
    Le Calvez-Kelm, Florence
    Ribeiro Pinto, Luis Felipe
    Herceg, Zdenko
    EPIGENETICS, 2011, 6 (10) : 1217 - 1227
  • [49] Systematic Identification of circRNA-miRNA-mRNA Regulatory Network in Esophageal Squamous Cell Carcinoma
    Shen, Yi
    Shao, Yi
    Niu, Chen
    Ruan, Xiaoli
    Zang, Zhaoping
    Nakyeyune, Rena
    Guo, Xiuhua
    Liu, Fen
    FRONTIERS IN GENETICS, 2021, 12
  • [50] Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma
    Zhang, Lu
    Dong, Bing
    Ren, Pengfei
    Ye, Hua
    Shi, Jianxiang
    Qin, Jiejie
    Wang, Kaijuan
    Wang, Peng
    Zhang, Jianying
    ONCOLOGY LETTERS, 2018, 16 (03) : 3303 - 3318